BioXcel Therapeutics, Inc. (BTAI)
Confidential investigation: officers & directors’ potential breach of fiduciary duties to investors.
Investigation
03/08/2021
Initial Lawsuit
03/08/2021
Lawsuit Progression
07/22/2021
Investigation regarding Plug Power’s review and assessment of the treatment of certain costs’ classification (Research and Development v. Costs of Goods Sold), the recoverability of right of use assets associated with certain leases, and internal controls.
03/02/2021
Plug Power discloses its inability to file its annual report on Form 10-K for the fiscal year ended December 31, 2020 on time:
“The Company is working diligently to complete the necessary work, including review and assessment of the treatment of certain costs with regards to classification between Research and Development versus Costs of Goods Sold, the recoverability of right of use assets associated with certain leases, and certain internal controls over these and other areas. It is possible that one or more of these items may result in charges or adjustments to current and/or prior period financial statements. The Company is still evaluating whether any such charges or adjustments would be required and, if required, whether any such charges or adjustments would be material; but any charges, if required, would be non-cash in nature and any such adjustments or charges would not impact the Company’s guidance on forward projections.”
Stock Impact
Close | Previous close | Price variation | Percentage variation |
---|---|---|---|
$48.78 | $52.46 | $-3.68 | -7.01% |
This is a class action on behalf of persons and entities that purchased or otherwise acquired Plug securities between November 9, 2020 and March 1, 2021, inclusive.
According to the complaint, defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the company’s business, operations, and prospects. Specifically, defendants allegedly failed to disclose to investors:
(1) that the Company would be unable to timely file its 2020 annual report due to delays related to the reviewof classification of certain costs and the recoverability of the right to use assets with certain leases;
(2) that the Company was reasonably likely to report material weaknesses in its internal controlover financial reporting;
(3) that, as a result of the foregoing, Defendants’ positive statementsabout the Company’s business, operations, and prospects were materially misleading and/or lackeda reasonable basis.
07/22/2021
The court issued an order appointing the lead plaintiff and lead counsel.
10/06/2021
This securities fraud class action is on behalf of a class of all persons who purchased Plug Power Inc. common stock on the open market of a U.S. stock exchange between November 9, 2020 and March 16, 2021, inclusive.
Operative complaint
Confidential investigation: officers & directors’ potential breach of fiduciary duties to investors.
Whether directors and officers of LegalZoom.com, Inc. (LZ) breached their fiduciary duties to the company and its shareholders.
Whether directors and officers of Amicus Therapeutics, Inc. (FOLD) breached their fiduciary duties to the company and its shareholders.
Whether directors and officers of Inari Medical, Inc. (NARI) breached their fiduciary duties to the company and its shareholders.
Whether directors and officers of Payoneer Global Inc. (PAYO) breached their fiduciary duties to the company and its shareholders.
Whether directors and officers of Kewaunee Scientific Corporation (KEQU) breached their fiduciary duties to the company and its shareholders.